SMART Fund Research Grant and Seed Grant Program

Grant Program

Each year, the Canadian Fertility and Andrology Society has the pleasure of awarding one SMART Fund Research Grant ($20000) and three Research Seed Grants ($5000 each) to our members. The SMART (Science and Medicine in Assisted Reproductive Technology) Fund is to initiate and assist furthering research and special projects that align with the CFAS’s mission and values. The Research Seed Grants promote collaboration across distinctly different fields. Seed Grants serve to provide financial assistance to initiate new research or to obtain the preliminary results necessary to start a new a research program that could subsequently be funded by regular grant agencies – a great opportunity to start a new and exciting project!

Closing date: May 12th, 2019 

Criteria for Selection

To be included in the judging, proposals must demonstrate that the research project involves collaboration between two or more primary investigators who work in different locations and who represent clearly distinct disciplines. 

Proposals will be judged on the following criteria:

  1. Quality of the scientific/research idea (20%)
  2. Originality of the idea (20%)
  3. The chances of success (20%)
  4. The value of the results to be obtained (20%)
  5. Qualification of the applicant or co-applicants (20%)

Selection Process

A sub-committee of the CFAS Board of Directors will review all applications.  The sub-committee shall consist of at least one member from the Board of Directors and shall include at least one basic scientist and one clinician. Proposals will be ranked according to the evaluation criteria outlined above. Successful applicants will be awarded funding subject to annual budgetary limits.  Primary Investigators must be CFAS members in good standing.

Funding Available in 2019

3 Seed Grants of $5000 each.

1 SMART Fund of $20000.

Process

Applications must be received at the CFAS office by May 12th, 2019 for consideration in the current year. Successful applicants will be notified by September 1st and announced publicly at the closing ceremony of the CFAS Annual Meeting.

Applications must conform to the instructions below:

  1. Individual applicants may only submit one proposal per year.
  2. Applicants must submit a mid-year report upon request from the Board of Directors
  3. The results of research projects must be submitted as an abstract and presented to the CFAS Annual Meeting of the following year. If absolutely no results are available for submission and presentation, a one-page report explaining the reasons must be sent to the CFAS Board.
  4. Applications are to be submitted on letter size (8.5 x 11 inches) paper, using 12-point Arial font, and be no longer than 2 pages, with the following format:

Include the following elements your application:

Project Title

Applicants

Principal Investigator (name, affiliations, primary place of work/employment)

Co-Investigator(s) (name, affiliations, primary place of work/employment)

Project description

Hypotheses to be tested, aim(s) of research and significance of research to the field of human reproduction and fertility

Rationale

Experimental design (if pertinent)

  1. Include study design (if pertinent)
  2. Include patient inclusion and exclusion criteria (if pertinent)
  3. Include number of patients, oocytes, embryos etc. (if pertinent)
  4. Include brief description of methodology
  5. Include endpoints of project and time line for milestones

Value of the information, including:

  1. To the scientist (e.g., preliminary results for a grant)
  2. To the clinic/physicians, embryologist, nurse etc.
  3. To the patient (population)

Ethics approval requirements (if required, funding will be held until proof of approval is received)

Budget (on a third page)

  1. Materials
  2. Salaries
  3. Other

Applicants

Short CVs (max 2 pages each) for each principal applicant and co-applicant. For the Principal and Co-Investigator, you must demonstrate that you meet the requirement for cross discipline collaboration. Please indicate the following:

  1. Primary career focus (i.e.: clinical care, biomedical research, etc.)
  2. Primary work location (be specific—university research lab, ART clinic, etc.)

Seed Grant

Process

Applications must be received at the CFAS office before April 30th, 2019 for consideration in the current year. Successful applicants will be notified by September 1st and announced publicly at the CFAS Annual Meeting.

Applications must conform to the instructions below:

Individual applicants may only submit one proposal per year.

Applicants must submit a mid-year report upon request from the Board of Directors

The results of research projects must be submitted as an abstract and presented to the CFAS Annual Meeting of the following year. If absolutely no results are available for submission and presentation, a one-page report explaining the reasons must be sent to the CFAS Board.

Applications are to be submitted on letter size (8.5 x 11 inches) paper, using 12-point Arial font, and be no longer than 2 pages, with the following format:

Include the following elements your application:

Project Title

Applicants

  1. Principal Investigator (name, affiliations, primary place of work/employment)
  2. Co-Investigator(s) (name, affiliations, primary place of work/employment)

Project description

  1. Hypotheses to be tested, aim(s) of research and significance of research to the field of human reproduction and fertility

Rationale

  1. Experimental design (if pertinent)
    • Include study design (if pertinent)
    • Include patient inclusion and exclusion criteria (if pertinent)
    • Include number of patients, oocytes, embryos etc. (if pertinent)
    • Include brief description of methodology
    • Include endpoints of project and time line for milestones
  1. Value of the information, including:
    • To the scientist (e.g., preliminary results for a grant)
    • To the clinic/physicians, embryologist, nurse etc..
    • To the patient (population)
  1. Ethics approval requirements (if required, funding will be held until proof of approval is received) 

Budget

  1. Materials
  2. Salaries
  3. Other

Applicants

  1. Short CVs (max 2 pages each) for each principal applicant and co-applicant. For the Principal and Co-Investigator, you must demonstrate that you meet the requirement for cross discipline collaboration. Please indicate the following:
    • Primary career focus (i.e.: clinical care, biomedical research, etc.)

 

SMART FUND GRANT

GENERAL TERMS AND CONDITIONS GOVERNING

A CFAS SMART FUND GRANT

DEFINITIONS

  1. Award Letter means the formal letter of award sent to the Principal Investigator by the CFAS and signed by both
  2. CFAS means the Canadian Fertility and Andrology
  3. Principal Investigator means the person named as such in the Grant Application, and who is the person who has primary responsibility for the design, conduct and supervision of the Research
  4. Grant means the funds awarded to the Principal Investigator for the purposes of funding the Research Project, in whole or in
  5. Institution means the institution(s) or facility(ies) in which the research will be conducted and who will be responsible for administering the
  6. Researcher means the Principal Investigator and any member of the team appointed by the Principal Investigator to conduct the Research
  7. Research Project or Project means the research project detailed in the Grant Application submitted to
  8. The SMART Fund (Science and Medicine in Assisted Reproductive Technology) is an internally restricted fund administered and managed by the CFAS in accordance with Terms of Reference dated June 2017, which may be updated from time to time.

 PURPOSE

  1. The purpose of the SMART Fund is to use funds to initiate, assist and further research and special projects which are aligned with the CFAS vision and
  2. These Terms and Conditions apply to each Researcher who is associated with, or performs research which is part of, the Research Project and to the

 RESEARCH

  1. The Research Project shall be carried out by the Principal Investigator and the Researcher, in accordance with acceptable research standards, the research policies of the Institution, and in accordance with the proposal approved by CFAS (attached to the Award Letter as Schedule "A").

 PRINCIPAL INVESTIGATOR

  1. Written notice will be provided to CFAS if the Principal Investigator is unable to carry out or complete the Research Project, and the replacement lead investigator will be subject to CFAS approval. If a replacement lead investigator cannot be identified within 90 days from the date on which the Principal Investigator resigns, CFAS may require that any unspent funds be returned to
  2. The Principal Investigator will ensure that the research is performed:
  • safely;
  • in accordance with all applicable laws;
  • objectively and to the highest ethical standards, and
  • in accordance with the requirements of the institution

 

  1. The Principal Investigator must be both a Canadian resident and a member in good standing of the CFAS at the time of funding and throughout the period in which the Research Project is
  2. The Principal Investigator will advise each other member of the research team of these terms and

 ETHICS REVIEW

  1. The Principal Investigator warrants that the Researcher has obtained permission to conduct any research involving humans from the ethics review board of the Institution or a nationally recognized independent ethics review board, and any research involving animals from an accredited institutional Animal Care
  2. In accepting the CFAS Smart Fund Grant, the Recipient agrees to comply with the Tri- Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2 (2014) and the Canadian Council on Animal Care

CONFLICTS OF INTEREST

The Principal Investigator must inform CFAS if any conflicts of interest arise that have the potential to impact upon the direction or outcomes of the Research

 GRANT

  1. The Grant is a one-time award, and shall not exceed the actual costs of the
  2. The amount of the Grant will not be
  3. No more than 15% of the Grant may be paid to the Institution as a contribution towards overhead
  4. Grant funds will be used exclusively to carry out the Research Project and are not transferrable.
  5. CFAS may withhold any funds not yet paid to the Principal Investigator under the Grant. if the Principal Investigator fails to submit any of the reports required by these
  6. 80% of the Grant will be paid to the Principal Investigator upon satisfaction of the following:
    • Confirmation that the research proposal has been approved by the Ethics Board or Committee of the Institution and/or Animal Care Committee; and
    • Execution of the Awards
  7. The balance of 20% of the Grant will be released to the Principal Investigator upon receipt of:
    • The report of the Principal Investigator that the Research has been completed;
    • Submission of a financial report showing that the full amount of the Grant was expended; and Submission to CFAS of a final report in the format referred to in the Award Letter.
  8. If less than the full amount of the Grant was expended, the amount paid to the Principal Investigator upon completion will be reduced

 

 INTERIM REPORTS

  1. The following interim reports will be provided to CFAS:

 

  • Within six months of the date of funding, the Principal Investigator shall advise CFAS that the Research Project has commenced;
  • Within twelve months of the date of funding, the Principal Investigator shall provide CFAS with a brief interim report detailing the status of the Research;
  • Additional details required to be included in any interim or final report may be set out in the Award Letter;
  • Within thirty days after the earlier of completion of the Project or 18 months after funding, the Principal Investigator shall provide CFAS with:
  • A final report detailing the principal results of the Research Project including listing any publications and/or presentations arising from the Research Project; and
  • A financial report prepared in a format like that of the budget submitted with the Grant application. Financial reports shall also be signed by the Principal Investigator and an authorized financial officer of the Institution. The report will include a certification of the amount of funds expended on the Research Project to the report

 

  1. Financial records for review by the CFAS or its accountants shall be kept for at least two years after the date on which the Project is
  2. CFAS shall have the right to decline to review future funding proposals made by the Principal Investigator or the Institution, if the Principal Investigator fails to submit the appropriate Interim and final

 OWNERSHIP AND SHARING OF RESEARCH RESULTS

  1. For the purposes of this Policy, “Publish” means to make the results of the Research public in any way by any means whether written or electronic or
  2. The Research results are the sole property of the research team or the Institution. CFAS does not have any right, title or interest in the research
  3. Sharing of Results: Results must first be offered for presentation at an Annual Scientific Meeting of the
  4. The Principal Investigator or Researcher will attend the CFAS meeting chosen by CFAS and present results as an oral communication at no additional expense to the

 PUBLICATION AND ACKNOWLEDGEMENT

  1. The Principal Investigator will ensure that the support of the CFAS is acknowledged any time that the results are made public or are Published by ensuring that the following language is added:

“This work was carried out with the aid of a grant from the Canadian Fertility and Andrology Society”

 LIMITATION OF LIABILITY

  1. In no event shall CFAS be responsible for any liability, financial or otherwise, arising directly or indirectly out of any act or omission of the Institution, the Principal Investigator or any other Researcher working on the Research Project including, but not limited to, the research conducted, the expenditure of the Grant funds, the conduct of the Principal Investigator and other Researchers and the use or Publication of the results.
  2. The Principal Investigator agrees, during and after the terms of the Grant, to indemnify and keep indemnified CFAS from and against any and all liability, loss, damage, cost or expenses which may result from the Principal Investigator’s, or any of its employees’ or licensees’, conduct in connection with the Grant.

 GENERAL TERMS

  1. This Agreement is not assignable in whole or in
  2. A material breach will give the non-breaching party the right to terminate this Agreement. If the Principal Investigator or the Researcher is in material breach, CFAS is entitled to demand a return of any unspent
  3. All representations, warranties, disclaimers, indemnifications and reporting obligations contained in this Agreement shall survive the date on which the Research Project has been
  4. No waiver of any provision of these Terms shall be deemed to constitute a waiver of any other provisions (whether similar); nor shall such waiver be binding unless executed in writing by the party to be bound by
  5. The Principal Investigator agrees that the Research Project shall be performed in accordance with all federal and provincial laws, and the rules and regulations of the Institution.

 NO RELATIONSHIP

  1. The Principal Investigator undertakes the Research on its own behalf and not on behalf of the CFAS, and this Agreement and the Grant shall not be construed as creating the relationship of principal and agent, of partnership in law; or of joint venture as between the Centre and the Principal Investigator or any other person involved in the Research Project.